Literature DB >> 32736750

Neuro-anesthesiology in pregnancy.

Kyra Bernstein1, Hanna Hussey1, Patrick Hussey1, Kaila Gordo1, Ruth Landau2.   

Abstract

Management of the pregnant patient requiring neurosurgery poses multiple challenges, juxtaposing pregnancy-specific considerations with that accompanying the safe provision of intracranial or spine surgery. There are no specific evidence-based recommendations, and case-by-case interdisciplinary discussions will guide informed decision-making about the timing of delivery vis-à-vis neurosurgery, the performance of cesarean delivery immediately before neurosurgery, consequences of neurosurgery on subsequent delivery, or even the optimal anesthetic modality for neurosurgery and/or cesarean delivery. In general, identifying whether increased intracranial pressure poses a risk for herniation is crucial before allowing neuraxial procedures. Modified rapid sequence induction with advanced airway approaches (videolaryngoscopic or fiberoptic) allows improved airway manipulation with reduced risks associated with endotracheal intubation of the obstetric airway. Currently, very few anesthetic drugs are avoided in the neurosurgical pregnant patient; however, ensuring access to critical care units for prolonged monitoring and assistance of the respiratory-compromised patient is necessary to ensure safe outcomes.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebrospinal fluid; Combined spinal–epidural; Epidural; General anesthesia; Intubation; Neuraxial; Neuro-anesthesiology; Spinal

Mesh:

Year:  2020        PMID: 32736750     DOI: 10.1016/B978-0-444-64239-4.00010-2

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  1 in total

Review 1.  Ten Rules for the Management of Moderate and Severe Traumatic Brain Injury During Pregnancy: An Expert Viewpoint.

Authors:  Simone Di Filippo; Daniel Agustin Godoy; Marina Manca; Camilla Paolessi; Federico Bilotta; Ainhoa Meseguer; Paolo Severgnini; Paolo Pelosi; Rafael Badenes; Chiara Robba
Journal:  Front Neurol       Date:  2022-06-09       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.